Go Pro
→ Oxford Club Analyst’s Urgent AI Warning (From The Oxford Club) (Ad)tc pixel Free SABSW Stock Alerts

SAB Biotherapeutics (SABSW) Competitors

SAB Biotherapeutics logo
$0.01 0.00 (-0.90%)
As of 03:13 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

SABSW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy SAB Biotherapeutics stock or one of its competitors? MarketBeat compares SAB Biotherapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SAB Biotherapeutics include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does SAB Biotherapeutics compare to Ainos?

Ainos (NASDAQ:AIMDW) and SAB Biotherapeutics (NASDAQ:SABSW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
SAB Biotherapeutics N/A N/A N/A

In the previous week, Ainos' average media sentiment score of 0.00 equaled SAB Biotherapeutics'average media sentiment score.

Company Overall Sentiment
Ainos Neutral
SAB Biotherapeutics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
SAB BiotherapeuticsN/AN/AN/AN/AN/A

Summary

Ainos beats SAB Biotherapeutics on 1 of the 1 factors compared between the two stocks.

How does SAB Biotherapeutics compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and SAB Biotherapeutics (NASDAQ:SABSW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
SAB Biotherapeutics N/A N/A N/A

In the previous week, Alvotech's average media sentiment score of 0.00 equaled SAB Biotherapeutics'average media sentiment score.

Company Overall Sentiment
Alvotech Neutral
SAB Biotherapeutics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$559.42MN/AN/AN/AN/A
SAB BiotherapeuticsN/AN/AN/AN/AN/A

Summary

Alvotech beats SAB Biotherapeutics on 1 of the 1 factors compared between the two stocks.

How does SAB Biotherapeutics compare to Aravive?

SAB Biotherapeutics (NASDAQ:SABSW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SAB BiotherapeuticsN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
SAB BiotherapeuticsN/A N/A N/A
Aravive N/A N/A N/A

In the previous week, SAB Biotherapeutics' average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
SAB Biotherapeutics Neutral
Aravive Neutral

Summary

Aravive beats SAB Biotherapeutics on 2 of the 2 factors compared between the two stocks.

How does SAB Biotherapeutics compare to Atlantic Coastal Acquisition Corp. II?

SAB Biotherapeutics (NASDAQ:SABSW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SAB BiotherapeuticsN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SAB BiotherapeuticsN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, SAB Biotherapeutics' average media sentiment score of 0.00 equaled Atlantic Coastal Acquisition Corp. II'saverage media sentiment score.

Company Overall Sentiment
SAB Biotherapeutics Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Summary

SAB Biotherapeutics and Atlantic Coastal Acquisition Corp. II tied by winning 0 of the 0 factors compared between the two stocks.

How does SAB Biotherapeutics compare to Biofrontera?

SAB Biotherapeutics (NASDAQ:SABSW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SAB BiotherapeuticsN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SAB BiotherapeuticsN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, SAB Biotherapeutics' average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
SAB Biotherapeutics Neutral
Biofrontera Neutral

Summary

Biofrontera beats SAB Biotherapeutics on 1 of the 1 factors compared between the two stocks.

Get SAB Biotherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SABSW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SABSW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SABSW vs. The Competition

Export
MetricSAB BiotherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$528.46M$7.01B$12.68B
Dividend YieldN/A3.90%2.67%9.42%
P/E RatioN/A3.4926.8823.95
Price / SalesN/A6,282.29518.3593.75
Price / CashN/A13.1350.6060.45
Price / BookN/A87.6810.566.16
Net IncomeN/A-$96.07M$3.60B$331.73M
7 Day PerformanceN/A-0.56%-2.15%-1.96%
1 Month PerformanceN/A0.11%0.10%-2.49%
1 Year PerformanceN/A56.20%22.55%17.21%

SAB Biotherapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SABSW
SAB Biotherapeutics
N/A$0.01
-0.9%		N/A-77.3%$0.00N/AN/A140
AIMDW
Ainos
N/A$0.14
-8.7%		N/A-37.5%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.18
+34.6%		N/A-90.6%$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SABSW) was last updated on 7/22/2026 by MarketBeat.com Staff.
From Our Partners
America’s answer to universal basic income
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
Elon is about to dominate the biggest arms race in tech history
Microsoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...
The Oxford Club | Sponsoredtc pixel
Wall Street legend put 60% in one stock — here’s the ticker
One of America's most famous investors put 60% of his fund into a single stock - and Whitney Tilson of Stansbe...
Stansberry Research | Sponsoredtc pixel
It all happens tonight.
Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...
Trade Thirsty | Sponsoredtc pixel
The options guide that actually starts at the beginning
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel